About HistoGenetics
HistoGenetics is a Healthcare company based in Ossining (United States) founded in 2006 by NEZIH CEREB. It offers high-resolution genetic sequencing and tissue-typing services for medical and research applications. It operates on a B2B model. The company has 42 employees. Its chief executive, as recorded, is NEZIH CEREB. Its Indian entity Histogenetics (India) Private Limited reported revenue of ₹8.35 Cr. HistoGenetics offers products and services including HLA Typing Service, Genomic Sequencing, Pharmacogenomics Testing, and ABO Rh Typing. Its focus areas include Genomics, Genetic Testing, HLA Sequencing and Life Sciences. Its competitors include Omniome, Rejuvenate Bio and Genewiz; 2 of its 3 listed competitors have raised funding.
Company details
HistoGenetics specializes in advanced HLA sequence-based typing and genomic services using technologies like PacBio and Illumina. They provide cost-effective testing for donor registries, transplant centers, and laboratories, focusing on immunogenetics and pharmacogenomics. Based in Ossining, NY, USA, they ensure high-quality assurance and fast turnaround for precision medicine applications, including whole genome sequencing and allele-level analysis.
- Headquarters Ossining, United States
- Employees 42
- Founders NEZIH CEREB
- SectorsHealthcare
- Phone•••• ••••
- Website histogenetics.com
- Social X Facebook
- Legal Name Histogenetics (India) Private Limited
- Date of Incorporation 18 Dec, 2006
- Jurisdiction Chennai, Tamil Nadu, India
- Indian entity revenue₹8.35 Cr
FY 2024 · -2% YoY
- Indian entity net profit₹71.6 Lakh
FY 2024 · 9% margin
- Indian entity EBITDA₹1.09 Cr
FY 2024 · 13% margin
- Employee Count42
Associated legal entities of HistoGenetics
HistoGenetics operates through Histogenetics (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Histogenetics (India) Private Limited CIN U72900TN2006PTC061761 | Active | 18 Dec 2006 | Chennai, Tamil Nadu | ₹8.3 Cr | 42 | 3 | View details |
Products & Services of HistoGenetics
HistoGenetics offers a comprehensive portfolio of products and services, including HLA Typing Service, Genomic Sequencing, Pharmacogenomics Testing, and ABO Rh Typing.
High-resolution sequencing for HLA genes in transplantation and research.
Whole genome analysis using PacBio for health and disease studies.
Testing for drug response variants like FCGR genes.
Predicts blood types through NGS for registry purposes.
Board of directors of Histogenetics (India) Private Limited (HistoGenetics)
Histogenetics (India) Private Limited is the primary company behind HistoGenetics. The board of Histogenetics (India) Private Limited currently have 3 directors; the longest-serving is Soo Young Lee, appointed in 2006. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Soo Young Lee DIN 01451180 | Director | 18 Dec 2006 | 19 yrs 10 mo | Histogenetics (India) Private Limited |
| Nezih Vahid Cereb DIN 01451283 | Director | 18 Dec 2006 | 19 yrs 10 mo | Histogenetics (India) Private Limited |
| Nagarajan DIN 07550128 | Director | 06 Jun 2016 | 10 yrs 4 mo | Histogenetics (India) Private Limited |
People of HistoGenetics
4 people are tracked at HistoGenetics (2 in leadership, 2 in team); the tracked headcount is 42.
| Name | Role | Group |
|---|---|---|
| CEO, Co-Founder | Leadership | |
Nagarajan Sridharan | Director | Leadership |
Jin Park | Information Technology Infrastructure Manager | Team |
anand sunku | Technical Lead | Team |
Complete people profiles for HistoGenetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of HistoGenetics
Figures of Histogenetics (India) Private Limited, the primary company behind HistoGenetics, for FY 2024. Revenue was ₹8.35 Cr (-2% year on year). Net profit was ₹71.6 Lakh (9% margin). EBITDA was ₹1.09 Cr (13% margin). Revenue has grown at a compounded annual rate of +9% over three years and -2% over five years.
- ₹8.35 CrRevenue · FY 2024 · -2% YoY
- ₹71.6 LakhNet profit · 9% margin
- ₹1.09 CrEBITDA · 13% margin
- ₹1 LakhPaid-up capital
- 42Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Histogenetics (India) Private Limited are on its company page.
Detailed financial statements for HistoGenetics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of HistoGenetics
HistoGenetics has 3 listed competitors in our database, 2 of them funded. They include Omniome, Rejuvenate Bio and Genewiz.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. |
Detailed competitors of HistoGenetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Genomics
3 companies that operate in the same segment as HistoGenetics (Clinical Genomics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about HistoGenetics
HistoGenetics was founded in 2006.
HistoGenetics is headquartered in Ossining, United States. It is registered at Ossining, New York, United States.
NEZIH CEREB is the CEO of HistoGenetics, as recorded in our data. They have also founded this company.
HistoGenetics has 42 employees.
The primary company behind HistoGenetics, Histogenetics (India) Private Limited, reported revenue of ₹8.35 Cr for FY 2024, down 2% year on year.
HistoGenetics specializes in advanced HLA sequence-based typing and genomic services using technologies like PacBio and Illumina. They provide cost-effective testing for donor registries, transplant centers, and laboratories, focusing on immunogenetics and pharmacogenomics. Based in Ossining, NY, USA, they ensure high-quality assurance and fast turnaround for precision medicine applications, including whole genome sequencing and allele-level analysis.
HistoGenetics's top competitors include Omniome, Genewiz and Rejuvenate Bio.
HistoGenetics offers HLA Typing Service, Genomic Sequencing, Pharmacogenomics Testing, and ABO Rh Typing.
HistoGenetics operates through Histogenetics (India) Private Limited.
The legal entities of HistoGenetics currently have 3 directors, including Nagarajan, Soo Young Lee, Nezih Vahid Cereb.